Actionable insights — Estée Lauder (EL): the turnaround-to-growth screen

1. The "turnaround morphing into growth" screen — buy the inflection, not the wreck

1. Start with a high-quality legacy brand whose chart "clearly went awry" — usually a post-2022 collapse off the Covid-stimulus high.
2. Diagnose the downfall to one or two identifiable, fixable causes (not secular decline). Here: China demand collapse + a botched acquisition write-down — both one-time, both addressable.
3. Confirm a credible fixer is in place: a new CEO with a named recovery plan, ~a year in, already showing traction (not just promising it).
4. Require evidence of the inflection — margins turning up, organic sales stabilizing, guidance being raised — before buying. You want the turn confirmed, not hoped for.

• Legacy names a year into a credible recovery plan where the most recent quarter shows margin expansion and raised guidance — the "morphing into growth" signal.

2. Use Price/Sales, not P/E, to value a turnaround

1. For a recovering company, ignore the headline P/E — collapsed margins shrink earnings, which mechanically inflates the P/E and makes a cheap stock look expensive.
2. Use Price/Sales (P/S) instead: revenue is far less distorted by the temporary margin trough, so P/S reveals the real depression in the valuation.
3. Anchor the upside to a P/S the stock has touched before (e.g. 3× sales) and compute the implied return at recovered margins.
4. Cross-check against P/E only on normalized (recovered) earnings, not trough earnings.

• Any "expensive on P/E but rock-bottom on P/S" name — that gap is the margin-recovery opportunity.

3. Margin + free-cash-flow inflection as the trigger — "the heart of a business"

1. Treat the most recent earnings report as the verification step: did gross margin, operating margin and free cash flow all turn up together?
2. Demand a large step-change, not a rounding error — the kind that signals the cost-cut/efficiency plan is hitting the bottom line.
3. FCF is the cleanest tell that the "hard part" is over: it's hard to fake and it funds the re-rating.

• The first quarter where margins and FCF jump together off a trough — that's the green light, even before the chart breaks out.

4. Headwind-to-tailwind reversal — the cause of the fall becomes the driver of the recovery

1. Identify the single biggest cause of the decline (here: China sales).
2. Check whether that same factor has now reversed direction — the most powerful turnarounds are when the thing that killed the stock starts driving it.
3. Quantify it (growth rate, share gains, management guidance pointing forward) to confirm it's structural, not a one-quarter bounce.

• The original problem region/product/segment turning positive on the latest print — confirmation the recovery has a durable engine.

5. Depressed-multiple re-rating math — size the asymmetry before buying

1. Establish the downside: a quality legacy brand with improving fundamentals limits how far it can fall.
2. Compute the upside from a multiple re-rating (P/S back to a historical level) plus recovering earnings — both legs compound.
3. Only act if the payoff is asymmetric (here: a possible double vs limited downside). If it isn't lopsided, pass.

• Setups where multiple expansion and earnings recovery point the same way — the two-engine re-rating.

6. Entry discipline — don't chase the pop; "know what you own and why"

1. If the stock has just spiked on news (here ~12% on the killed Puig merger), wait for it to "ease back" rather than buying the spike.
2. Frame the position by its timeframe: a turnaround is a 2–3-year hold, "an investment, not a trade" — size and patience accordingly.
3. Hold only what you can explain: everything in the portfolio is there "for a reason" — be able to articulate the thesis and the catalyst.

• News-driven spikes as a reason to wait, not buy; a clear "why I own this and for how long" before sizing in.